ChemicalBook > CAS DataBase List > (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Structure
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
  • CAS No.2088771-61-1
  • Chemical Name:(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
  • CBNumber:CB23371367
  • Molecular Formula:C16H13F6N5O2
  • Formula Weight:421.3
  • MOL File:2088771-61-1.mol
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Property
  • Melting point >189°C (dec.)
  • Density 1.67±0.1 g/cm3(Predicted)
  • storage temp. -20°C Freezer, Under inert atmosphere
  • solubility DMSO (Slightly), Methanol (Slightly)
  • pka 12.02±0.40(Predicted)
  • form Solid
  • color White to Off-White
  • InChI InChI=1S/C16H13F6N5O2/c17-9-6-11(19)10(18)4-7(9)3-8-5-12(28)23-1-2-27-13(14(29)24-8)25-26-15(27)16(20,21)22/h4,6,8H,1-3,5H2,(H,23,28)(H,24,29)/t8-/m1/s1
  • InChIKey CJUCSNDPMOGZTM-MRVPVSSYSA-N
  • SMILES N1[C@H](CC2=CC(F)=C(F)C=C2F)CC(=O)NCCN2C(C(F)(F)F)=NN=C2C1=O
  • FDA UNII 6EV5E35ZMR
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal word
  • Hazard statements
  • Precautionary statements

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Chemical Properties,Usage,Production

  • Uses (10R)-Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes.
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Preparation Products And Raw materials
Raw materials
Preparation Products
Global(71)Suppliers
  • Supplier:
    BOC Sciences
  • Tel:16314854226;<br/>+16314854226
  • Email:inquiry@bocsci.com
  • Country:United States
  • ProdList:19654
  • Advantage:58
  • Supplier:
    Standardpharm Co. Ltd.
  • Tel:86-714-3992388
  • Email:overseasales1@yongstandards.com
  • Country:United States
  • ProdList:14332
  • Advantage:58
  • Supplier:
    Finetech Industry Limited
  • Tel:+86-27-87465837<br/>+8618971612321
  • Email:info@finetechnology-ind.com
  • Country:China
  • ProdList:9642
  • Advantage:58
  • Supplier:
    sgtlifesciences pvt ltd
  • Tel: +8617013299288
  • Email:dj@sgtlifesciences.com
  • Country:China
  • ProdList:12373
  • Advantage:58
  • Supplier:
    Moxin Chemicals
  • Tel: +8617320513646
  • Email:Anna@molcoo.com
  • Country:China
  • ProdList:9434
  • Advantage:58
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Spectrum
2088771-61-1, (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dioneRelated Search:
  • 其它杂质
  • 062-西格列汀
  • 杂质对照品
  • 西格列汀(制剂)十元环杂质
  • 环肽类
  • 药物杂质
  • 杂质
  • 对照品-杂质对照品
  • C16H13F6N5O2
  • 西格列汀USP杂质(BP:FP-B)
  • (R)-10-(2,4,5-三氟苄基)-3-(三氟甲基)-6,7,10,11-四氢-[1,2,4]三唑并[3,4-C][1,4,7]三氮杂环癸烷-8,12(5H,9H)-二酮
  • (R)-西格列汀EP杂质FP-B
  • 西他列汀片EP杂质EP-B
  • 西格列汀杂质56
  • (R)-10-(2,4,5-三氟苄基)-3-(三氟甲基)-6,7,10,11-四氢-[1,2,4]三唑[3,4-C] [1, 4,7] 三嗪 -8,12-(5H,9H) - 二酮(西格列汀杂质)
  • 西他列汀杂质60
  • 西格列汀FP杂质B
  • 西他列汀杂质71
  • 西格列汀十元环杂质FP-B
  • 西格列汀BP杂质FP-B
  • 西他列汀三嗪胺类似物
  • 西格列汀三嗪类似物
  • (10R)-6,7,10,11-四氢-3-(三氟甲基)-10-[(2,4,5-三氟苯基)甲基]-1,2,4-三唑[3,4-C][1,4,7]三氮杂癸烷-8,12(5H,9H)-二酮
  • 西格列汀十元环制剂
  • 西格列汀十元环制剂杂质
  • 西他列汀FP杂质B
  • 西格列汀杂质19
  • 西格列汀十元环杂质
  • 2088771-61-1
  • Sitagliptin (R)-Triazecine Analog
  • 1,2,4-Triazolo[3,4- c ][1,4,7]triazecine-8,12(5 H ,9 H )-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-, (10 R )-/Sitagliptin Triazecine Analog
  • (R)-Sitagliptin Tablets EP Impurity FP-B ((R)-Sitagliptin Triazecine Analog)
  • Sitagliptin Triazecine Impurity
  • (R)-Sitagliptin Tablets EP Impurity FP-B
  • (10R)-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-5H,6H,7H,8H,9H,10H,11H,12H-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12-dione
  • (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione? (Sitagliptin Impurity)
  • Sitagliptin Impurity FP-B
  • (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
  • Sitagliptin FP Impurity B/ Sitagliptin Triazecine Analog
  • (10R)?- 6,?7,?10,?11-?Tetrahydro-?3-?(trifluoromethyl)?-?10-?[(2,?4,?5-?trifluorophenyl)?methyl]?-1,?2,?4-?triazolo[3,?4-?c]?[1,?4,?7]?triazecine-?8,?12(5H,?9H)?-?dione
  • 1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-, (10R)-
  • Sitagliptin impurity 6/Sitagliptin FP Impurity B/Sitagliptin Triazecine Analog/10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro [1,2,4] triazolo [3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
  • (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)
  • Sitagliptin FP Impurity B
  • Sitagliptin-17
  • Sitagliptin Impurity 20
  • Impurity FP-B